MNMyo T. Naung

Myo T. Naung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Myo T. Naung has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protective immunity to clinical malaria is modified by the genetic diversity of P. falciparum antigens

    by Myo T. Naung, Ramin Mazhari, Rhea J. Longley, Somya Mehra, Wilson Wong, Paolo Bareng, Moses Laman, Benson Kiniboro, Maria Ome-Kaius, Pascal Michon, et al.

  • Open Access

    Assessing the effect of parasite antigen genetic diversity on performance of Plasmodium vivax serological exposure markers for malaria: a multicentre observational diagnostic accuracy study

    by Alison Paolo N Bareng, Kenneth W Wu, Eizo Takashima, Dionne C Argyropoulos, Lauren Smith, Myo T Naung, Ramin Mazhari, Kael Schoffer, Nicholas Kiernan-Walker, Anju Abraham, et al.


  • Open Access

    Targeting PTRAMP-CSS potently inhibits P. falciparum across blood, liver and mosquito stages

    by Pailene S. Lim, Nicolai C. Jung, Mikha Gabriela, Jelte M. M. Krol, Kitsanapong Reaksudsan, Myo T. Naung, Danushka S. Marapana, Rainbow W.B. Chan, Diana Nyabundi, Jedida Mwacharo, et al.

    Malaria, caused by Plasmodium falciparum spans liver, blood, and mosquito stages, limiting the effectiveness of single-stage vaccines. The PTRAMP-CSS heterodimer, a core component of the essential PCRCR invasion complex, is expressed on merozoites, mature gametocytes, and salivary gland sporozoites, enabling single-antigen targeting across multiple lifecycle stages. Nanobodies against PTRAMP-CSS block merozoite invasion of erythrocytes, reduce mosquito infection in membrane-feeding assays, and inhibit sporozoite invasion of primary human hepatocytes. High-resolution crystal structures of inhibitory and non-inhibitory nanobody-antigen complexes identify conserved inhibitory epitopes and guide the design of bispecific nanobody Fc constructs with enhanced potency. In semi-immune Kenyan CHMI samples, higher baseline IgG to PTRAMP-CSS and Ripr is associated with improved parasite control. By demonstrating conserved vulnerability across all three major lifecycle stages, PTRAMP-CSS offers a realistic path to single-antigen, multistage vaccines and biologics that aim to prevent disease and block transmission.

  • Open Access

    Molecular basis for the role of Ripr in Plasmodium falciparum invasion of human erythrocytes

    by Xiao Xiao, Qingmiao Zhou, Danushka F. Marapana, Thomas C McLean, Rainbow W. B. Chan, Shabih Shakeel, Andrew Leis, Pailene S Lim, Nicolai C. Jung, Myo Naung, et al.

    Plasmodium falciparum causes the majority of severe malaria, and merozoite invasion of erythrocytes is a vulnerable, antibody‑accessible step of the blood‑stage cycle. PfRipr is an essential component of the PCRCR invasion complex, yet the structural basis for antibody‑mediated neutralisation remains unclear. Here, we map inhibitory and non‑inhibitory epitopes across PfRipr and show that all potent inhibitors localise to the tail region (EGF6-8). Crystal structures reveal that inhibitory antibodies restrict the flexibility surrounding EGF7. Indeed, EGF7 buried surface area correlates strongly with inhibitory potency, identifying this domain as the principal invasion inhibitory determinant. Pairwise antibody combinations revealed unexpected synergy, with non‑inhibitory mAbs potentiating anti‑Rh5 activity. Conditional deletion, sequence replacement or positional swapping of EGF6-8 abolished invasion, demonstrating that both sequence and spatial arrangement are indispensable. These data define EGF7 as a conserved, functionally essential vulnerability and provide a blueprint for rational EGF6-8 immunogen design capable of eliciting P. falciparum strain‑transcending protection against blood‑stage malaria.


  • Open Access

    Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens

    by Alison Paolo N Bareng, Myo T Naung, Eli Martin, Somya Mehra, Jacob E Munro, Shannon Takala Harrison, Alyssa E Barry

    Background: Knowledge of the genetic diversity of Plasmodium vivax antigen vaccine candidates can offer valuable insights into antigens targeted by host immunity and their utility as vaccine candidates. We previously catalogued the genetic diversity of DBP, MSP1, and members of the RBP family. Here we report the diversity of 14 additional P vivax vaccine candidates to identify polymorphic domains and immune selection, to guide selection of alleles for vaccine development. Methods: A total of 289 of 353 publicly available P vivax whole genome sequences from Asia, the Americas, and Oceania passed a stringent variant-calling pipeline. Measures of diversity and balancing selection were calculated both across linear gene sequences and 3-dimensional (3D) proteins. Results: The blood-stage antigens AMA1, CyRPA, RBP1a, and P41 exhibited high genetic diversity and signatures of balancing selection on both linear and 3D structures. These signatures were consistent across all endemic regions, suggesting that these polymorphic loci are under immune selection. In contrast, CSP, TRAP, MSP4, MSP9, MSP10, GAMA, S12, ARP, S25, and S28 antigens showed low to intermediate genetic diversity and variable patterns among countries. Haplotype networks identified common variants that may represent antigenically distinct clusters. Importantly, sequences from the vaccine strain Sal-1 have extremely low global frequencies. Conclusions: AMA1, CyRPA, RBP1a, and P41 are under strong immune selection, while other antigens show limited diversity. Current vaccine formulations based on Sal-1 may have limited efficacy. Our results provide a framework for vaccine developers to select more common variants.


  • Open Access

    Association of a novel IgG3 allele with malaria in children from the Sepik region of Papua New Guinea

    by Maria Saeed, Elizabeth H Aitken, Myo T Naung, Caitlin Bourke, Kenneth W Wu, Rhea J Longley, Amy W Chung, Timon Damelang, Benson Kiniboro, Ivo Mueller, et al.

    Background: Susceptibility to malaria can be influenced by host genetic factors, including immune response genes. Antibodies against Plasmodium antigens are known to play an important role in protection from clinical disease. Polymorphisms in these antibodies may result in different functional properties that could provide protection from malaria. Methods: Immunoglobulin G1 (IgG1) and IgG3 alleles and IgG3 hinge region were investigated by polymerase chain reaction (PCR) and Sanger sequencing in a longitudinal cohort of children aged 1-3 years (N=203) from East Sepik region of Papua New Guinea (PNG). Linear regression was used to investigate associations between immunoglobulin alleles and Plasmodium infections. Results: Seventy-eight percent of the children were either heterozygous (n=82, 40%) or homozygous (n=77, 38%) for IGHG3*30 (G3m29), a novel IgG3 allele. G3m29 has a long hinge region of 4 exons. Significantly fewer Plasmodium spp. infections were observed in children with the IGHG3*30 allele compared to children without the allele (β= -1.736, 95% CI [-3.39, -0.079], p=0.038). This effect was most noticeable for Plasmodium vivax asymptomatic infections as IGHG3*30 carriers had on average one fewer infection in the 18-month follow-up period as compared to non-IGHG3*30 allele carriers (β= -1.06; 95% CI [-2.01, -0.12], p=0.028). Additionally, IGHG3*30 allele carriers had significantly lower levels of IgG to P. vivax vaccine candidate proteins compared to non-IGHG3*30 allele carriers. Conclusions: The IGHG3*30 allele is highly prevalent in the East Sepik region and is associated with fewer Plasmodium spp. infections.


  • Open Access

    Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea

    by Myo T. Naung, Elijah Martin, Wilson Wong, Zahra Razook, Digjaya Utama, Andrew J. Guy, Shannon Takala Harrison, Alan F. Cowman, Enmoore Lin, Benson Kiniboro, et al.

    Plasmodium falciparum Reticulocyte Binding Protein Homologue (RH5), a leading malaria vaccine candidate, is essential for erythrocyte invasion by the parasite, interacting with the human host receptor, basigin. RH5 has a small number of polymorphisms relative to other blood-stage antigens, and in vitro studies have shown that vaccine-induced antibodies raised against RH5 are strain-transcending, however most studies investigating RH5 diversity have been done in Africa. Understanding the genetic diversity and evolution of malaria antigens in other regions is important for their validation as vaccine candidates. In this study the rh5 gene was sequenced in 677 samples from a longitudinal cohort of Papua New Guinean (PNG) children aged 1-3 years. Of 677 samples successfully sequenced, 566 were identified as independent infections (i.e. one of each pair of identical sequences within hosts were removed). A total of 14 non-synonymous polymorphisms were identified, eight that are ‘common’ in the population (minor allele frequency > 1%), with 44 haplotypes ranging in frequency from 1% to 21%. Modeling of common SNPs to the cryo-EM structure of the RH5/CyRPA/RIPR complex mapped them to the Basigin binding site and near the contact point of CyRPA. Tajima’s D analyses of the corresponding nucleotide sequences produced positive values indicating potential hotspots of balancing selection. We attempted to confirm whether these signals were due to immune selection by measuring the rate of polymorphism between independent infections within the same host, and the association with clinical symptoms, however, no such associations were identified. Together these results suggest that while there is evidence of balancing selection driving RH5 diversity in the PNG P. falciparum population, immune escape was not observed within the cohort of young children. Limited immunity and therefore low selective pressure may explain this result, alternatively other evolutionary forces may contribute to balancing selection at the RH5-BSG binding interface in PNG.

  • Open Access

    VIVID: a web application for variant interpretation and visualisation in multidimensional analyses

    by Swapnil Tichkule, Yoochan Myung, Myo T. Naung, Brendan R. E. Ansell, Andrew J. Guy, Namrata Srivastava, Somya Mehra, Simone M. Caccio, Ivo Mueller, Alyssa E. Barry, et al.

    Large-scale comparative genomics- and population genetic studies generate enormous amounts of polymorphism data in the form of DNA variants. Ultimately, the goal of many of these studies is to associate genetic variants to phenotypes or fitness. We introduce VIVID, an interactive, user-friendly web application that integrates a wide range of approaches for encoding genotypic to phenotypic information in any organism or disease, from an individual or population, in three-dimensional (3D) space. It allows mutation mapping and annotation, calculation of interactions and conservation scores, prediction of harmful effects, analysis of diversity and selection, and 3-dimensional (3D) visualisation of genotypic information encoded in Variant Call Format (VCF) on AlphaFold2 protein models. VIVID enables the rapid assessment of genes of interest in the study of adaptive evolution and the genetic load, and it helps prioritising targets for experimental validation. We demonstrate the utility of VIVID by exploring the evolutionary genetics of the parasitic protist Plasmodium falciparum , revealing geographic variation in the signature of balancing selection in potential targets of functional antibodies.


  • Open Access

    Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria

    by Zalak Shah, Myo T. Naung, Kara A. Moser, Matthew Adams, Andrea G. Buchwald, Ankit Dwivedi, Amed Ouattara, Karl B. Seydel, Don P. Mathanga, Alyssa E. Barry, et al.

    Individuals acquire immunity to clinical malaria after repeatedPlasmodium falciparuminfections. Immunity to disease is thought to reflect the acquisition of a repertoire of responses to multiple alleles in diverse parasite antigens. In previous studies, we identified polymorphic sites within individual antigens that are associated with parasite immune evasion by examining antigen allele dynamics in individuals followed longitudinally. Here we expand this approach by analyzing genome-wide polymorphisms using whole genome sequence data from 140 parasite isolates representing malaria cases from a longitudinal study in Malawi and identify 25 genes that encode possible targets of naturally acquired immunity that should be validated immunologically and further characterized for their potential as vaccine candidates.